Skip to content

RxSight, Inc. RXST Enterprise value

Enterprise value at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
$66.56M-55.5%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$1.26B+40.8%
Precision Optics Corporation logo
Precision Optics CorporationPOCI
$41.57M+33.0%
Bausch + Lomb logo
Bausch + LombBLCO
$10.39B+6.9%
Glaukos logo
GlaukosGKOS
$6.25B+12.5%

Other financials

Income statement

See full
Revenue$30.9M-18.5%
Gross profit$23.5M-17.1%
Operating income-$17.8M-67.0%
Net income-$15.9M-93.9%
EPS (diluted)-$0.38-90.0%

Balance sheet

See full
Cash & equivalents$17.6M-37.2%
Total debt$10.8M-10.1%
Total equity$267.3M-4.3%
Total assets$304.0M-2.9%

Cash flow

See full
Operating cash flow-$10.9M-23.3%
CapEx$759.0K+32.0%
Free cash flow-$11.7M-23.8%

Valuation

See full
Market cap$232.23M-56.8%
P/S1.8×-1.8×

Profitability

See full
Gross margin77%+5.1pp
Operating margin-43.4%+128pp
Net margin-36.6%-867pp
FCF margin-16.9%+4.9pp

Returns & leverage

See full
Return on equity-17.1%+12.6pp
Debt / equity0.0×
Current ratio10.2×-2.5×

Where this comes from

Calculated from RxSight, Inc.’s reported figures.

The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about RxSight, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RxSight, Inc.'s enterprise value?
RxSight, Inc. (RXST) reported enterprise value of $247.45M in Q1 2026.
How has RxSight, Inc.'s enterprise value changed year-over-year?
RxSight, Inc.'s enterprise value decreased by 75.4% year-over-year, from $1.01B to $247.45M.
What is the long-term trend for RxSight, Inc.'s enterprise value?
Over 4 years (2021 to 2025), RxSight, Inc.'s enterprise value has grown at a 6.3% compound annual growth rate (CAGR), from $329.11M to $419.53M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.